IRD SCHEDULE 13G: SEC filing
A Schedule 13G was
Filed with the SEC on · accession 0002012383-26-003823
IRD filed a SCHEDULE 13G (schedule 13g) with the SEC on Oct 27, 2026. A Schedule 13G was filed regarding Opus Genetics, Inc. (IRD), indicating a passive ownership position by a reporting person. The stock moved +4.2% by the first close after the filing.
Summary of the filing
A Schedule 13G was filed regarding Opus Genetics, Inc. (IRD), indicating a passive ownership position by a reporting person. The filing directory contains only index and exhibit files, with no substantive ownership details available in the provided text.
Key details
How IRD stock reacted
Close before
$3.32
Oct 26, 2026
First close after
+4.22%
$3.46
5 trading days
+11.45%
$3.70
Since filing
+26.81%
$4.21
✦ Ask GOAX AI about this filing — what it means for IRD, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IRD?
Click hereFrequently asked questions
What did IRD file with the SEC on Oct 27, 2026?
IRD filed a SCHEDULE 13G (SEC filing). A Schedule 13G was filed regarding Opus Genetics, Inc. (IRD), indicating a passive ownership position by a reporting person. The filing directory contains only index and exhibit files, with no substantive ownership details available in the provided text.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did IRD stock react to this filing?
IRD closed at $3.32 before the filing and $3.46 on Oct 27, 2026 (+4.22%). Five trading days later: $3.70 (+11.45%).
Other IRD SEC filings
- 8-K · Executive departureOct 21, 2026
- 8-K · SEC filingOct 15, 2026
- 8-K · SEC filingSep 11, 2026
- 8-K · Fda approvalSep 9, 2026
- S-3 · Shelf registrationAug 7, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · Guidance raiseAug 6, 2026
- 8-K · SEC filingJun 16, 2026
- 8-K · SEC filingJun 16, 2026
- S-3 · Shelf registrationJun 5, 2026
Get alerts when IRD files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days